Caveolin-1 regulates corneal wound healing by modulating Kir4.1 activity.
The expression of caveolin-1 (Cav1) in corneal epithelium is associated with regeneration potency. We used Cav1(-/-) mice to study the role of Cav1 in modulating corneal wound healing. Western blot and whole cell patch clamp were employed to study the effect of Cav1 deletion on Kir4.1 current density in corneas. We found that Ba(2+)-sensitive K(+) currents in primary cultured murine corneal epithelial cells (pMCE) from Cav1(-/-) were dramatically reduced (602 pA) compared with those from wild type (WT; 1,300 pA). As a consequence, membrane potential was elevated in pMCE from Cav1(-/-) compared with that from WT (-43 ± 7.5 vs. -58 ± 4.0 mV, respectively). Western blot showed that either inhibition of Cav1 expression or Ba(2+) incubation stimulated phosphorylation of the EGFR. The transwell migration assay showed that Cav1 genetic inactivation accelerated cell migration. The regrowth efficiency of human corneal epithelial cells (HCE) transfected with siRNA-Cav1 or negative control was evaluated by scrape injury assay. With the presence of mitomycin C (10 μg/ml) to avoid the influence of cell proliferation, Cav1 inhibition with siRNA significantly increased migration compared with control siRNA in HCE. This promoting effect by siRNA-Cav1 could not be further enhanced by cotransfection with siRNA-Kcnj10. By using corneal debridement, we found that wound healing was significantly accelerated in Cav1(-/-) compared with WT mice (70 ± 10 vs. 36 ± 3%, P < 0.01). Our findings imply that the mechanism by which Cav-1 knockout promotes corneal regrowth is, at least partially, due to the inhibition of Kir4.1 which stimulates EGFR signaling.
Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical College, Xuzhou, China; and Department of Pharmacology, New York Medical College, Valhalla, New York.
Chengbiao
C
Zhang
Department of Pharmacology, New York Medical College, Valhalla, New York.
Xiaotong
X
Su
Department of Pharmacology, New York Medical College, Valhalla, New York.
Lars
L
Bellner
Department of Pharmacology, New York Medical College, Valhalla, New York daohong_lin@nymc.edu.
Dao-Hong
DH
Lin
D000818:Animals; D051242:Caveolin 1 / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D002465:Cell Movement; D065306:Corneal Injuries / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D004195:Disease Models, Animal; D019573:Epithelium, Corneal / Q000293:injuries / Q000378:metabolism* / Q000473:pathology; D066246:ErbB Receptors / Q000378:metabolism; D005838:Genotype; D006801:Humans; D008564:Membrane Potentials; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010641:Phenotype; D010766:Phosphorylation; D011188:Potassium / Q000378:metabolism*; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics / Q000378:metabolism*; D061251:Primary Cell Culture; D034622:RNA Interference; D015398:Signal Transduction; D014162:Transfection; D014945:Wound Healing; D000098854:Kcnj10 Channel
C495541:Cav1 protein, mouse; D051242:Caveolin 1; D000098854:Kcnj10 Channel; D024661:Potassium Channels, Inwardly Rectifying; C541485:EGFR protein, mouse; D066246:ErbB Receptors; D011188:Potassium
Kcnj10; caveolin-1; corneal wound healing